Sponsored by:

Molecular Imaging: Page 497

MDS Nordion, Molecular Insight Pharmaceuticals partner
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion and Molecular Insight Pharmaceuticals have signed a six-year renewable contract to manufacture and supply Zemiva, a molecular imaging pharmaceutical being developed for cardiac ischemia.
February 15, 2006
ART to buy Alerion
By AuntMinnie.com staff writers
Optical molecular imaging developer ART Advanced Research Technologies has reached an agreement to purchase substantially all of the imaging technology and product assets of U.S. biomarker and contrast media developer Alerion Biomedical.
February 14, 2006
Imagin taps Oliverio
By AuntMinnie.com staff writers
PET and PET/CT imaging center developer Imagin Molecular has appointed Positron president Joseph Oliverio as CEO.
February 14, 2006
Positron opens Chinese joint venture
By AuntMinnie.com staff writers
PET vendor Positron of Houston has officially launched its joint venture with Neusoft Medical Systems of China.
February 12, 2006
CMS, NOPR to collect PET data
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) said it will be working with the National Oncologic PET Registry (NOPR) to collect data nationwide to assist in managing patients with various forms of cancer.
February 9, 2006
Draxis shows 2005 revenue growth
By AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health reported solid gains in revenues and a slight dip in net income for its 2005 fiscal year (end-December 31).
February 9, 2006
Digirad partners with Ultrascan
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad has signed a personal services and management agreement with mobile ultrasound services provider Ultrascan of Suwanee, GA.
February 8, 2006
SPECT/CT helps clarify ambiguous bone foci
By Jonathan S. Batchelor
Bone scintigraphy with SPECT has a good track record for detecting metastatic areas with a high lesion-to-background contrast. But a drawback of SPECT has been that anatomic details can be lacking. Researchers from Germany, however, have found that SPECT/CT can increase specificity in cases when SPECT alone is equivocal.
February 8, 2006
IsoRay adds medical advisor
Medical isotope developer IsoRay Medical has appointed Dr. Steven Kurtzman as medical advisor.
January 31, 2006
GE launches Ventri cardiac gamma camera
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., is launching a new dual-head gamma camera targeted at the nuclear cardiology market.
January 31, 2006
VisualSonics licenses contrast agent
By AuntMinnie.com staff writers
Microimaging ultrasound developer VisualSonics of Toronto said that it is licensing a contrast agent for the quantification of myocardial perfusion in preclinical studies from the University of Virginia in Charlottesville, VA.
January 25, 2006
Scintigraphy shows breast cancer response to hormone therapy sooner
By Shalmali Pal
Only a third of breast cancer patients who have endocrine therapy respond to treatment, and the current tests for patient selection are less than optimal. Some imaging techniques may not show results for several months post-treatment. Scintigraphy could be a better, noninvasive way to predict treatment response, according to European researchers.
January 25, 2006
2006 01 25 15 53 01 706
Previous Page
Page 497 of 615
Next Page